As of Apr 20
| +0.82 / +2.66%|
The 7 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 35.00, with a high estimate of 40.00 and a low estimate of 30.00. The median estimate represents a +10.64% increase from the last price of 31.64.
The current consensus among 7 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.